25 February 2026
25 February 2026
Children are protected against fewer diseases as per the new schedule, which the states say will damage public health.
The funding aligns with the in-licensing of SLTE-1009, an anti-PACAP monoclonal antibody acquired from DartsBio Pharmaceuticals.
The collaboration integrates Demeetra’s CleanCut CHO platforms and cell line services with NorthX Biologics’ GMP manufacturing expertise.
The aim of the pathway is to remove red tape for bespoke therapies designed for patients with rare diseases.
This deal adds two more siRNA candidates to GSK’s pipeline, which the company is looking to expand as it looks to offset the impacts of key patent expiries within its portfolio.
The submission includes data indicating a meaningful survival benefit for infantile-onset NPC patients treated with adrabetadex.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
